| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $158M | — | — | — | — |
| Op. Income | $50M | — | — | — | — |
| Gross Margin | 35.6% | — | — | — | — |
| Net Margin | 24.7% | — | — | — | — |
| EPS (Diluted) | $0.33 | — | — | — | — |
| Free Cash Flow | $31M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $158M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $56M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $6M |
| Other Expenses | $0 |
| Operating Expenses | $6M |
| Cost & Expenses | $109M |
| OPERATING INCOME | $50M |
| Interest Income | $3M |
| Interest Expense | $39M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $33M |
| D&A | $42M |
| EBIT | $50M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $158M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $56M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $6M |
| Other Expenses | $0 |
| Operating Expenses | $6M |
| Cost & Expenses | $109M |
| OPERATING INCOME | $50M |
| Interest Income | $3M |
| Interest Expense | $39M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $33M |
| D&A | $42M |
| EBIT | $50M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $39M |
| Depreciation & Amortization | $42M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$2M |
| Change in Working Capital | -$21M |
| OPERATING CASH FLOW | $58M |
| Capital Expenditure | -$27M |
| Acquisitions (Net) | $12M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $9M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$6M |
| Net Debt Issuance | -$239M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$6M |
| Other Financing Activities | $213M |
| NET CASH FROM FINANCING | -$32M |
| FREE CASH FLOW | $31M |
| Net Change in Cash | $34M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $137M |
| Short-Term Investments | $0 |
| Net Receivables | $31M |
| Inventory | $0 |
| Other Current Assets | $118M |
| TOTAL CURRENT ASSETS | $299M |
| PP&E (Net) | $2.8B |
| Goodwill | $37M |
| Intangible Assets | $14M |
| Long-Term Investments | $2.0B |
| Tax Assets | $286.0K |
| Other Non-Current Assets | $33M |
| TOTAL NON-CURRENT ASSETS | $4.8B |
| TOTAL ASSETS | $5.1B |
| Account Payables | $9M |
| Short-Term Debt | $525M |
| Deferred Revenue | $35M |
| Other Current Liabilities | $113M |
| TOTAL CURRENT LIABILITIES | $707M |
| Long-Term Debt | $596M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $223.0K |
| Other Non-Current Liabilities | $71M |
| TOTAL NON-CURRENT LIABILITIES | $2.2B |
| TOTAL LIABILITIES | $2.9B |
| Common Stock | $1.8B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $19M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.1B |
| Minority Interest | $43M |
| TOTAL EQUITY | $2.2B |
| TOTAL LIABILITIES & EQUITY | $5.1B |
| Total Debt | $2.7B |
| Net Debt | $2.6B |
